Efficacy and safety of cholinesterase inhibitors in Alzheimer's disease: a meta-analysis
BACKGROUND: Cholinesterase inhibitors (ChEIs) are the only drugs marketed for the treatment of Alzheimer's disease. Despite numerous randomized controlled trials, the efficacy and safety of this group of medications has not been quantified. Our objective was to quantitatively summarize data on the e...
Na minha lista:
| Publicado no: | CMAJ |
|---|---|
| Principais autores: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Canadian Medical Association
2003
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC191283/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12975222/ |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|